KMAB Survey Results: Knowledge Management And Decision Making In Pharma And Biotech

  • White Paper

📊Survey Alert: We present findings from a survey of 33 pharmaceutical and biotech industry professionals on knowledge management and decision making – including the use of TPPs, AI, and company-wide knowledge systems.

Read the Survey Report: Knowledge Management and Decision Making in Pharma and Biotech – April 2024 Survey Results

Discover what industry professionals really think about how decisions are made, where knowledge management falls short, and what needs to change.

  • Learn why 75% of respondents say a pre-defined decision framework is critical.
  • Understand the split on whether Target Product Profiles (TPPs) are essential or just nice to have.
  • Explore where AI fits – and where it’s still finding its footing – in pharma decision making.

Stay informed on the evolving landscape of drug development decision-making – download now and see how your company’s practices compare to industry peers.

Download file

Please register below to access the full content

Member Sign in

Access your saved articles, exclusive insights, and personalized recommendations.

Welcome back, your personalized
learning experience awaits.

Gain full access to exclusive resources, webinars, and insights designed to help you grow and stay ahead.

  • Access exclusive research, whitepapers & case studies
  • Attend member-only webinars and live events
  • Get early invitations to expert roundtables and workshops
  • Save and organize your favorite resources
  • Receive personalized recommendations based on your interests
  • Join a community of professionals and innovators

Stay informed. Stay connected. Stay ahead.

Published by: Red Sequoia

Red Sequoia is a digital agency building websites, web apps, SEO, and marketing for mission-driven organizations, with a strong focus on ecology and sustainability.

Related Resources

Best Practices for using AI to Summarize Congress Abstracts

Having worked closely with Medical Affairs and MSL teams across hundreds of scientific congresses —

Read More

Selecting a Compound for Drug Development – The Importance of Knowledge Management – Part 1

On May 6, Hari Patel, Doug Foster, Ben Weintraub, and John Panaccione from the inPhronesis

Read More

Landing Resource Page

Change the content 330+ companies presented at JPM 2025. Everyone’s writing what they noticed. We

Read More

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.